Biochimica et Biophysica Acta, 1027 (1990) 287-294
287
Elsevier
BBAMEM 74948
Effect of local anaesthetics on steroid-nicotinic acetylcholine
receptor interactions in native membranes of Torpedo marmorata
electric organ
H.R. Arias 1, M.B. S a n k a r a m 2, D. M a r s h 2 and F.J. Barrantes 1
J Instituto de Inoestigaciones Bioquimicas, Consejo Nacional de Inoestigaciones Cientificas y Tecnicas and Unioersidad Nacional del Sur,
Bahia Blanca (Argentina) and 2 Max-Planck-lnstitut far biophysikalische Chemie, Abteilung Spektroskopie, Gi~ttingen (F.R.G.)
(Received 19 February 1990)
Key words: Nicotinic acetylcholinereceptor; Fluorescencequenching; Cholesterol; Spin label; ESR; (Torpedo marmorata)
Interactions between steroids and the nicotinic acetylcholine receptor (AChR) have been studied in native membrane
vesicles from Torpedo marmorata electric organ by electron spin resonance 0ESR) and fluorescence techniques. ESR
spectra of spin-labelled cholestane (CSL) revealed that this steroid probe was incorporated into the AChR-rich
membrane vesicles in regions which were to a certain extent enriched preferentially in the steroid, both in the presence
and in the absence of local anaesthetics. Since the nitroxide group present in CSL is also a paramagnetic quencher of
the intrinsic protein fluorescence, this property was used to characterize the AChR-steroid interactions. The quenching
induced by CSL was sensitive both to AChR concentration and to the action of cholinergic agonists. In competition
experiments, the ability of CSL to quench the AChR intrinsic fluorescence was markedly inhibited by benzocaine,
tetracaine and QX-222 (a quaternary trimethylammonium derivative of iidocaine), and was totally inhibited by procaine.
The effectiveness of local anaesthetics in inhibiting CSL-induced quenching followed the order: procaine >> benzocaine
>_.tetracaine > QX-222. This inhibition effect was shown not to be charge-dependent. The data can be interpreted in
terms of a model requiring specific association sites for local anaesthetics on the hydrophobic surface of the AChR
which at least partially overlap with those for steroids.
Introduction
The nicotinic acetylcholine receptor (AChR) is a
pentameric glycoprotein located in the postsynaptic
membrane (for a review, see Ref. 1). All subunits form
the wall of a cation-selective channel which is chemically gated by the neurotransmitter acetylcholine. The
transient opening of the channel results in ion transport
through the membrane. However, the persistent presence of agonist leads to desensitization of the AChR, a
state associated with impaired ion conductance. Whether
the lipid environment is able to modulate the function
of the AChR has been the subject of various investigations (for a recent review, see Ref. 2).
Abbreviations: AChR, nicotinic acetylcholinereceptor; ESR, electron
spin resonance; Hepes, N-(2-hydroxyethyl)piperazdne-N'-2-ethanesulfonic acid; CSL, 4',4'-dimethylspiro[5-a-cholestane-3,2'-oxazolidin]-3'-yloxyl;CCh, carbamoycholinehydrochloride.
Correspondence: F.J. Barrantes, Instituto de Investigaciones Bioquimicas, Consejo Nacional de InvestigacionesCientificasy Tecnicas,
Universidad Nacional del Sur, 8000 Bahia Blanca, Argentina.
Because of the high levels of cholesterol in the electric organ of Torpedinidae and native membranes isolated therefrom [3,4], this steroid could potentially play
a role in receptor function. There have been reports on
the steroid and cholesterol requirements during solubilization and reincorporation of the AChR in order to
maintain the agonist-induced state transitions [5]. When
studying the effect of lipid composition on vesicle structure and A C h R function, Criado et al. [6] found that a
cholesterol analogue was necessary to mimic the kinetics of agonist-induced state transitions and for achieving maximal ion-flux responses. The enhancement of
agonist-induced ion-fluxes by cholesterol in reconstituted systems [7,8] has also been reported. Cholesterol
depletion from A C h R membranes increases the affinity
of the receptor for agonist binding, concomitantly decreasing ion flux [9]. In reconstituted planar bilayers,
cholesterol enhances the conductance and cooperativity
of the ion channel [10]. There are at least two possibihties by which cholesterol exerts its effects on AChR
functional properties: (1) by influencing the bulk physical properties of the membrane, or (2) by modulating
A C h R activity through association sites on the protein
0005-2736/90/$03.50 © 1990 ElsevierSciencePublishers B.V. (Biomedical Division)
288
surface. The former possibility is suggested by the high
endogenous cholesterol levels of native AChR-rich
membranes [3,4]. The second possibility is suggested by
electron spin resonance spectroscopy (ESR) data [1113], showing that spin-labelled androstanol, a steroid
analogue, exhibits a high affinity for AChR. The results
of labelling all AChR subunits by a photoreactive
cholesterol analogue [14] lend further support to the
second hypothesis. Jones and McNamee [15] have proposed the existence of nonannular sites for cholesterol.
Non-competitive blockers of the AChR are a heterogeneous group of compounds that includes aminated
local anaesthetics. These compounds alter the steadystate agonist dose-response relationship without significantly altering the apparent dissociation constant. Three
different mechanisms have been postulated to explain
their blocking action: (1) plugging of the open channel,
thus blocking ion translocation by steric hindrance (reviewed in Ref. 16); (2) allosteric conformational changes
of the receptor involving channel closing and accelerated desensitization [17]; and (3) blocking of the
physiological response by an indirect interaction via the
lipids surrounding the receptor in the plasma membrane
[18]. Heidmann et al. [19] have suggested two different
types of sites for local anaesthetic substances: (a) a
unique high-affinity site that is histrionicotoxin-sensitive; and (b) several low-affinity sites, which are
histrionicotoxin-insensitive and are located at the lipid/
protein interface.
In this paper, we have studied the interaction between a spin-labelled steroid, local anaesthetics, and the
AChR. We have taken advantage of the fact that the
nitroxide group attached to the steroid nucleus exhibits
paramagnetic quenching of the intrinsic protein fluorescence to characterize these interactions. Finally, we
have used permanently charged molecules, such as QX222 (the trimethylammonium derivative of lidocaine),
uncharged local anaesthetics, such as benzocaine, and
molecules such as procaine and tetracaine, where the
charge is pH-dependent (cf. Fig. 1), to focus on the
effect of net charges on the ligand-receptor interactions.
Materials and Methods
Materials
Torpedo marmorata specimens from the Bay of
Arcachon, France, were generously provided by Prof.
Dr. V. Whittaker (Max-Planck-Institut flir biophysikalische Chemie, G~Sttingen, F.R.G.). The fish were maintained in aquaria for two months until use. N-[propionyl-3H]Propionylated a-bungarotoxin (spec. act. 107
Ci/mmol) was purchased from Amersham International, Buchs, U.K. DEAE-cellulose sheets (DE-81) were
obtained from Whatman Inc. (Clifton, N.J.). Percoll
(density 1.030 g/ml) was obtained from Pharmacia
(Uppsala, Sweden). The spin-labelled cholestane analogue (4',4'-dimethylspiro[5-a-cholestane-3,2'-oxazolidin]-3'-yloxyl) was purchased from Syva (Palo Alto,
CA). Procaine-, tetracaine- and carbamoylcholine-hydrochloride, and benzocaine were obtained from Sigma
Chemical Co. (St. Louis, MO). QX-222 (a trimethylammonium derivative of lidocaine) was from Astra
(Sweden). All other reagents were of the highest purity
available.
Methods
Purification of A ChR-rich membrane vesicles. The fish
were killed by pithing, the electric organs were dissected
and rapidly used for the preparation of AChR-containing membranes following the methods of Lindstrom et
al. [20] or Barrantes [21]. Where indicated, sealed and
leaky vesicles were further fractionated by the method
of Sachs et al. [22], based on the exchange of Na ÷
within the vesicles for external Cs + and subsequent
separation on a Percoll-CsC1 density gradient. The
specific activity of the AChR membranes was assayed
using the a-[3H]bungarotoxin/DE-81 ion-exchange
filter paper method [23]. Typically values of 900-1700
pmol a-[3H]bungarotoxin/mg protein were obtained.
Protein was determined according to the method of
Lowry et al. [24] using bovine serum albumin as standard. In the case of vesicles obtained by Percoll-CsC1
density gradient, blanks containing Percoll-CsCl were
subtracted.
ESR experiments. Sealed membrane vesicles were
centrifuged in an Eppendorf centrifuge for 15 min at
full speed in order to remove the remaining Percoll-CsC1.
The floating layer was washed with 10 mM Hepes, (pH
8.0). The pellet (0.3 mg protein) was resuspended in 1
ml buffer and supplemented with 10/~g CSL previously
dissolved in absolute ethanol (1% of the total volume).
Membrane and probe were allowed to interact at room
temperature for 30 min. In competition experiments,
membranes were preincubated with different local
anaesthetics for 30 rain. The membrane suspensions
were subsequently incubated with CSL for an additional 30 min at a local anaesthetic/CSL molar ratio
of 29.6, 32.7, and 53.9 for tetracaine, procaine, and
benzocaine, respectively. Membrane samples were then
centrifuged at 45 000 rpm in a Beckman 50 Ti rotor for
45 min and the pellets were transferred to ESR sample
capillaries (1 mm i.d.) and concentrated in a bench top
centrifuge. To minimize the signal from water, the samples were trimmed to a height of 10 mm by carefully
removing excess vesicle suspension and supernatant.
ESR spectra were recorded with a Varian E-12 Century
Line spectrometer equipped with a nitrogen gas-flow
temperature regulation system. Temperatures were measured to + 0.1 °C with a thermocouple placed just above
the cavity within the sample capillary. ESR spectra were
collected using an IBM personal computer with a
289
Labmaster
interface
(12 bit A/D
resolution)
using
software written by Dr. M.D. Ring (Max-Planck-Institut fur biophysikallische
Chemie) and stored as 1
kword data files. For further details of the ESR techniques, see Ref. 44.
Fluorescence measurements.
For protein intrinsic fluorescence determinations
50-100 pg AChR membrane
protein (40-130 nM a-[ 3H]bungarotoxin
binding sites)
were used. In all cases the membranes
were resuspended
by brief sonication
(10 s) in 1 ml of 100 mM sodium
phosphate buffer (pH 8.0). To desensitize AChR, membranes were resuspended
in the same buffer containing
100 PM CCh and incubated
for 60 min. To determine
the steady-state
fluorescence
of the protein, membrane
suspensions
were placed in 1 X 1, 0.7 X 0.7, or 0.5 x 1
(cm x cm) quartz cuvettes, excited at 285 nm and recorded in a spectrofluorimeter
(SPF-500 Aminco-Bowman) at an emission wavelength of 340 nm. The excitation and emission bandpass
was 5 nm. In the case of
desensitization
experiments,
the fluorescence
emission
spectra of the protein were recorded between 300 and
400 nm. The spectra were stored and their corresponding areas integrated using a Bascom-Turner
Instrument
(MA, U.S.A.). The fluorescence
emission spectra and
intensities
of the local anaesthetics
were determined
in
control experiments,
at 300-400 nm with 285 nm excitation. In the particular
case of procaine,
increasing
aliquots of the drug were added to the AChR suspension and the total fluorescence was measured at 340 nm.
Quenching experiments.
Aliquots of an isopropanol
solution of CSL were added to the AChR suspension
and allowed to interact for at least 1 h before fluorescence measurements.
All values were corrected for dilution. In order to correct for trivial absorption
from the
CSL at the excitation and emission wavelengths used in
the quenching
experiments,
the absorption
of CSL was
determined
in buffer. The static absorption
factor thus
obtained,
I, was used to correct the apparent quenching. The actual paramagnetic
quenching
by the nitroxide group covalently
attached to the steroid nucleus
was obtained from the formula:
L
tively. To minimize
the CSL absorption
at the excitation wavelength
a 0.5 x 1 cm cuvette was used with the
0.5 pathlength
along the excitation axis.
Local anaesthetic treatment. AChR membranes
were
preincubated
with local anaesthetic
at room temperature or at 4°C for l-2 h before addition of CSL. Of the
local anaesthetics
used in this study, only benzocaine
and procaine exhibited
a measurable
intrinsic
fluorescence in the same range as that of the AChR protein.
The contribution
of procaine and benzocaine
fluorescence was determined
as previously described, and subtracted from the observed total intensity. zyxwvutsrqponmlkjihgfe
Results
ESR spectra of spin-labelled cholestane
Fig. 1 shows the different
local anesthetic
compounds used in the present study.
The ESR spectra of CSL incubated
with AChR-rich
membrane
vesicles in the presence and absence of various local anaesthetics
are given in Fig. 2. The spectra
are characteristic
of anisotropic
rotation of the molecule
about its long axis, indicating
that CSL is incorporated
in the membrane.
The ESR spectra are rather similar,
both in the presence and absence of the different local
anaesthetics.
In all cases, the spectra exhibit a limited
degree of spin-spin broadening,
indicating
that at least
part of the spin-labelled
steroid is preferentially
concentrated
in localized regions of the membrane.
The
same phenomenon
has been observed for spin-labelled
phosphatidylcholine
and phosphatidylethanolamine
[12],
and most probably
reflects an intrinsic property of the
high packing density in the AChR-rich
membranes.
In
the presence of benzocaine,
this effect is even more
pronounced.
As a result of the spin-spin
broadening
of the ESR
spectra, it is difficult to resolve components
in the wings
ax-222
zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCB
= FadI
where
Benzocoine
“ZN
i-O,,
and F,,, ad Fappare
Procome
H2N
C-OCH2CH2-N
2 CH 3
,C2H3
the corrected and apparent fluorescence intensities
after CSL quenching,
respectively,
[C] is the concentration
of CSL used in the fluorescence
quenching experiments,
and [C,,] and [C,,] are the CSL
concentrations
used to determine absorption
at the excitation (A,,) and emission (A,,)
wavelengths,
respecare the pathlengths
of the
tively, and L,, and L,,
cuvette along the excitation and emission axes, respec-
‘C2H3
0
HsCr \
N
Tetracoine
H’
!-OCH
2 CH 2 -NNCH3
‘CH)
Fig. 1. Molecular structures of the local anaesthetics
study.
used in this
290
a
spectra according to the modified Stern-Volmer equation [45], which effectively assumes the existence of two
fluorophore populations, one accessible and the other
inaccessible to the quencher:
F o / ( Fo - F ) =
\
(1)
1/(LKQICSLI) + 1 / L
0
C
Fig. 2. (a) Molecular structure of spin-labelled cholestane (CSL). (b)
ESR spectra of CSL in AChR-rich membrane vesicles from T.
m a r m o r a t a , at 22°C. Native membranes (C), were preincubated with
procaine (P), tetracaine (T) and benzocaine (B) for 30 min and then
allowed to interact with CSL for 30 rain. Total scan width is
100 gauss.
of the spectra corresponding to CSL molecules that are
motionally restricted by direct interaction with the
AChR protein. However, comparison with previous resuits [11], indicates that CSL certainly does not exhibit
the strong selectivity for the protein shown by spinlabelled androstanol or fatty acids. It is likely that its
degree of association with the AChR is similar to, or
smaller than, that of phosphatidylcholine or phosphatidylethanolamine [12]. In view of these uncertainties, it
is not possible to deduce from the ESR spectra whether
the local anaesthetics decrease the degree of association
of CSL with the protein.
where F0 is the initial AChR fluorescence intensity, and
F is the fluorescence intensity of AChR in the presence
of a given concentration, [CSL], of nitroxide. The value
of I/KQ, which can be defined as the CSL concentration at which 50% of the initial intensity is quenched
assuming that all fluorophores are fully accessible to
quencher, allows one to compare quantitatively the efficiency of quenching by CSL under different conditions. The other parameter characterizing the qenching
is the apparent fraction of fluorophores, fa, with effective quenching constant, KQ.
The analysis of the modified Stern-Volmer plots (Fig.
3, inset), revealed that the fluorescence of AChR in the
desensitized state was 4.7-fold more efficiently quenched
by CSL than in the resting state (Table I).
Modified Stern-Volmer plots for CSL-induced
quenching in membrane preparations containing different specific concentrations of AChR are given in Fig.
4A, and Table I summarizes the quenching data. The
quenching efficiency with the membranes of higher
specific activity, corresponding to 130 nM AChR, was
5.4-fold higher than that with the lower specific activity
membranes, which corresponded to 46 nM AChR. The
fa and KQ values summarized in Table I are plotted
against AChR concentration in the resting state in Fig.
4B. The negative slope observed in the plot of fa with
increasing AChR concentration contrasts with the opposite trend found for the KQ values.
100
8
8 5o
y
0.0
Quenchinq of A ChR intrinsic fluorescence spin-labelled
cholestane
Typical fluorescence emission spectra obtained with
excitation at 285 nm are shown in Fig. 3. Upon addition
of CSL to the native membrane from T. marmorata, the
intrinsic fluorescence of the AChR protein was efficiently quenched by the nitroxide group attached to the
CSL. Quenching parameters were obtained from these
0.2
0.4
[Ch - S k ] - 1, ,u.M- 1
wavelength Into)
3" 5
Fig. 3. (a) Fluorescence emission spectra of 120 nM AChR-rich
membranes from T. m a r m o r a t a . (b-f) Quenching elicited by increasing concentrations of CSL. CSL concentrations were (in/~M): 2.2 (b),
8.8 (c), 17.6 (d), 33.0 (e) and 63.8 (f). (Inset) Modified Stern-Volmer
plots for CSL quenching of intrinsic fluorescence from AChR in
different conformational states. Temperature, 20°C.
291
TABLE I
TABLE II
Efficiency of spin-labelled cholestane in quenching the AChR intrinsic
fluorescence
Effect of local anaesthetics on quenching of the AChR intrinsic fluorescence by spin-labelled cholestane
The apparent quenching parameters were obtained from the modified
Stern-Volmer plots of Figs. 3 (inset) and 4A, where fa = 1/intercept is
the apparent fraction of the fluorophores accessible to CSL; KQ =
intercept/slope, is the apparent Stern-Volmer quenching constant of
the accessible fraction of fluorophores. 1/KQ, is the relative CSL
concentration at which 50% of the fluorescence intensity is quenched
if fluorophores are totally accessible to quencher (f~ ~ l ) . r, is the
correlation coefficient of the linear regression. It is assumed that most
of the AChR is in the resting state in the absence of agonist. The
desensitized state is reached upon 60 min incubation of the membrane-bound AChR with 0.1 mM CCh.
The apparent quenching parameters were obtained from the data of
Figs. 5 and 6. Other details are given in the legend to Table I.
Conformational
state
[AChR]
nM
fa
Resting
Resting
Resting
Desensitized
46
130
120
120
0.98
0.45
0.59
0.28
KQ
I /KQ
(M -z)
(/~M)
3.8.104
2.0.105
7.1.104
3.3.10 ~
26.5
4.9
14.2
3.0
Anaesthetic
Concn.
(pM)
fa
KQ
(M -~)
I/KQ
(~M)
r
None
QX-222
Tetracaine
Benzocaine
Procaine
30
30
30
3
0.45
0.38
0.31
0.99
0.99
2.0-105
6.5-104
5.0.104
1.8.104
2.6.104
4.9
15.4
19.8
56.3
38.0
0.986
0.995
0.991
0.980
0.998
r
Fig. 5 compares the modified Stern-Volmer plots of
AChR membranes pretreated with tetracaine, benzocaine and QX-222, respectively. The quenching parameters, summarized in Table II, demonstrate a lower efficiency of CSL-induced quenching upon exposure of
0.984
0.986
0.999
0.939
1.0.
10-
Pg
O
(B)
20 x
0
0
I
I
0
v
5.
0.5"
,10 ~"
I
0
41,.-
I
0
0.0
I
0.0
I
0.2
0.4.
[ C h - S L ] - 1 p,M- 1
0
160
!
80
[AChR], nM
0
Fig. 4. (A) Modified Stern-Volmer plots for CSL quenching of intrinsic fluorescence from AChR membranes with different specific activities,
corresponding to 46 nM ( o ) and 130 nM (e) AChR sites. Temperature, 20°C. (B) Fraction of accessible fluorophores ( f v left scale) and quenching
constant (KQ, right scale) as a function of AChR concentration for a fixed membrane concentration.
40.
30.
L,..
20"
10'
0.0
S
I
!
0.2
0.4.
0.0
I
!
0.2
0.4,
[Ch-SL]- 1 ,u,M-1
Fig. 5. Modified Stern-Volmer plots for CSL quenching of intrinsic fluorescence from AChR membranes pretreated with local anaesthetics. 130 nM
AChR membranes were preincubated, as described under Materials and Methods, with 30 /tM of the local anaesthetics indicated and then
incubated with the given concentrations of CSL at 20°C.
292
1
20
o,,
0.0~
l
0
~
J
20
t
40
~
60
•
[Ch-SL], ,u,M
Fig. 6. Directplots of the fractionof residualAChRfluorescenceas a
function of CSL concentration,after preincubation with procaine at
the concentrationsindicated.Temperature,20°C.
the AChR to local anaesthetics. The effects observed
with procaine deserve special attention. Procaine inhibited completely the ability of CSL to quench the
AChR fluorescence (Fig. 6).
These experiments demonstrate that the relative efficiency of local anaesthetics in inhibiting the CSL-induced quenching of AChR fluorescence follows the
order: procaine >> benzocaine >_. tetracaine > QX-222.
Procaine was about 20-fold more efficient than either
QX-222 or tetracaine, and approximately 6-fold more
efficient than benzocaine, in inhibiting quenching of
AChR fluorescence by CSL.
Discussion
Interactions between CSL and the A ChR
The fluorescence properties of the AChR in its native, membrane-bound state [25,26], or in solubilized
form [27], are typical of those found for integral membrane proteins. Fifty Trp and 80 Tyr residues are present in Torpedo californica AChR [28]. The tryptophan
residues dominate the fluorescence of the protein, but
only one Trp is postulated to occur in the transmembrane region in both the 4- [28] and the 5-chain [29]
AChR models. This residue may be accessible to
quenching by CSL from the bilayer region, as was
postulated to be the case with brominated lipids [15].
However, the nitroxide group of CSL is located close to
the lipid/water interface [43], which most probably
allows this spin label to quench fluorophores in the
extramembranous domain of the AChR. This latter
possibility is suggested by the relatively high levels of
quenching (37-57%) produced by CSL in native
AChR-containing membranes. On the other hand, the
complexity of the fluorescence from a multifluorophore
protein such as the AChR [30] precludes over-detailed
interpretations from simple quenching experiments.
Previous studies have shown that the intrinsic fluorescence of the AChR in native membranes is effectively quenched by spin-labelled fatty acids and
androstanol [11,26]. Spin-labelled androstanol and CSL
are steroid analogues which differ from the naturally
occurring cholesterol either in the location or absence,
respectively, of the steroid -OH group. It has been
demonstrated that about 70 #M spin-labelled androstanol is needed to inhibit 50% of the AChR intrinsic
fluorescence [11]. The present results (Table I) show
that CSL was between 2.5- and 13.6-fold more efficient
than spin-labelled androstanol. This can be explained in
terms of the different location of the paramagnetic
nitroxide group relative to the membrane surface [43]
and hence to the accessible tryptophan chromophores
of the AChR [1l]. In view of the high specificity of the
androstanol analogue for the AChR [13], which it is
clear from the ESR data presented here is not shared by
the cholestane analogue (CSL), it is likely that the latter
is the more appropriate analogue for studying the behaviour of the natural steroid, cholesterol.
The higher efficiency of CSL-induced quenching observed with desensitized AChR in comparison with resting AChR agrees with previous studies using spinlabelled stearic acid [11] and acrylamide [26] to assess
the apparent accessibility of the AChR fluorophores
from the lipid and aqueous phases, respectively, in the
presence of the agonist suberyldicholine. Gonzalez-Ros
et al. [31], however, have observed a lower accessibility
of nitromethane to pyrene residues covalently attached
to the AChR, in the desensitized state. From the results
presented here, we interpret the observed changes in
CSL quenching efficiency upon addition of cholinergic
ligands as being due to changes in the exposure of
AChR fluorophores to quencher molecules accessing
the AChR through the lipid matrix. Furthermore, the
results suggest that the occupancy of agonist sites in the
extracytoplasmic domain of the a-subunits might induce local conformational changes with a relatively long
time span (seconds to minutes), which are sensed over
the quite considerable distances to the lipid/protein
interface.
The lower fraction of accessible fluorophores ( f a)
observed at higher relative AChR concentrations (Fig.
4B) suggests a phenomenon of fluorophore dilution.
This could be explained by postulating that the sites at
which CSL quenching takes place in the AChR present
a lower number of fluorophores than in other non-receptor proteins present in the postsynaptic membrane.
Thus, when the concentration of AChR is increased
relative to other membrane proteins, the mean number
of fluorophores diminishes. In contrast, quenching efficiency increases at higher specific AChR concentra-
293
tions, suggesting a preferential interaction of CSL with
association sites on the AChR (Fig. 4B).
Effect of local anaesthetics on CSL quenchinq properties
The fluorescence quenching method can be used to
test the displacement of boundary lipids by other hydrophobic molecules such as fatty acids, cholesterol and
local anaesthetics [32]. Thus, the question of whether
local anaesthetics interact with AChR at steroid sites
can be answered from the quenching properties of CSL
in AChR membranes pretreated with local anaesthetics.
Patch-clamp studies on myocytes of Xenopus laevis have
demonstrated that the reduction in burst durations
elicited by the general anaesthetic halothane was modulated by the level of cholesterol in the membrane [33].
Hille [34] has suggested that the pharmacological
effect and rates of action of local anaesthetics depend
on the relative population of uncharged/charged
species. The neutral form would be more accessible to
the excitable membrane than the cationic protonated
species, thus explaining the faster rate of action of the
former. Local anaesthetics that have tertiary amine
headgroups, like procaine and tetracaine, may acquire a
proton and a positive charge (see molecular structures
in Fig. 1), depending on the pH of the medium. The
intrinsic pK values of tertiary amines lie in the pH
range 8.0-9.0. The interfacial pK of the membranebound form will be reduced by approx. 1 pH unit, due
to the lower polarity at the membrane surface [46]. Thus
at the pH used here, the effect of tertiary amine local
anaesthetics represents the sum of the populations of
uncharged and charged molecules within the membrane,
which is dominated by the neutral species.
The present results indicate that local anaesthetics
compete with steroids for association sites on the AChR,
with the following effectivity: procaine >> benzocaine >_
tetracaine > QX-222. The order based on head-group
charge at pH 8.0, on the other hand, would be: QX-222
(permanently charged, trimethylammonium derivative
of lidocaine) >> procaine (intrinsic pK 8.9) > tetracaine
(intrinsic pK 8.2) > benzocaine (permanently uncharged). Thus, no simple relationship exists between
net headgroup charge of the local anaesthetics and their
effect on the steroid-AChR association sites.
Previous ESR experiments have dealt with charge
effects on the interaction of spin-labelled local
anaesthetics with the AChR, with somewhat diverse
results. Thus, Earnest et al. [35,36] and Blanton et al.
[37] have indicated that the positively charged form of
spin-labelled intracaine gives rise to a higher proportion
of the protein-associated species, whereas Horvath et al.
[38], utilizing spin-labelled procaine and its thioester
analogue, concluded that it is the uncharged form that
has a greater degree of association with the protein. The
former results are in agreement with the greater effectiveness of the charged cationic form of the drug in
blocking receptor-mediated ion translocation measured
by 86Rb+ flux [39], and with single-channel data on
AChR [17] which suggest that local anaesthetic effects
on AChR require that the molecule be positively
charged. However, the latter ESR results [38] and the
evidence that benzocaine, an uncharged local anaesthetic, blocks acetylcholine-activated ion channels [40],
strongly suggest the opposite. No single model is therefore able to account wholely for the local anaesthetic
effects.
Relationship between local anaesthetic and steroid sites
On the basis of the relative association constants
determined by ESR, Horvath et al. [38] have divided the
specificities of spin-labelled local anaesthetic analogues
into three groups. Benzocaine, tetracaine, and procaine
would be considered as drugs of high, medium, and low
specificity, respectively, according to such a classification. In addition, the fraction of spin-labelled local
anaesthetic analogues partitioning in the lipid phase
follows the order: benzocaine > procaine >_.tetracaine,
which corresponds approximately to the above pattern
of specificity. This is in agreement with Koblin and
Lester [18], who have previously reported that the effect
of the more hydrophobic local anaesthetics are voltageindependent and have potencies that parallel their hydrophobicity. The fact that benzocaine has a greater
effect on quenching by CSL than either tetracaine or
QX-222 may be due to this property. On the other
hand, the apparent equilibrium constant for the binding
of benzocaine to its blocking site [40] is within a factor
of five of those obtained for AChR-channel block by
the charged drug QX-222 [17] and the partially ionized
drug procaine [16]. This may also account for the greater
effect of benzocaine in comparison to QX-222 on CSLinduced quenching. However, the lower specificity of
spin-labelled procaine and the higher and approximately equivalent apparent equilibrium constants for
benzocaine and QX-222, respectively, contrast strongly
with the almost complete inhibition of the CSL-induced
quenching by procaine. The data can be reconciled with
a model postulating the existence of relatively specific
sites for local anaesthetics on the hydrophobic surface
of the AChR, which partially overlap with those for
steroids. In the special case of procaine, the results
strongly suggests a high degree of overlap.
In addition to the high affinity site for androstanol in
the annular environment of the AChR [13], Jones and
McNamee [15] have proposed the existence of nonannular sites for cholesterol at the interstices between the
five AChR subunits. The existence of a putative hydrophobic path allowing uncharged local anaesthetics to
interact with high affinity sites in the lumen of the
AChR-channel has also been postulated [37,41,42]. An
alternative mechanism of local anaesthetic action can
thus be suggested, based on the intercalation of mole-
294
cules in non-annular sites normally occupied by steroids
in a hydrophobic corridor between AChR subunits.
Such a corridor could provide a low affinity pathway to
allow local anaesthetics to reach their high affinity sites
inside the AChR channel. This suggestion is, however,
highly speculative.
Acknowledgements
This work was supported by grants from the Consejo
Nacional de Investigaciones Cientificas y Tecnicas
(CONICET) and Fundaci6n Antorchas, Argentina, and
the Volkswagen Stiftung, F.R.G.H.R.A. was supported
by a Deutscher Akademischer Austauschdienst e.V.
(DAAD) fellowship.
References
1 Barrantes, F.J. (1988) in Physical properties of biological membranes and their functional implications (Hidalgo, C., ed.), pp.
147-175, Plenum Press, New York, London.
2 Barrantes, F.J. (1989) Crit. Rev. Biochem. Mol. Biol. 24, 437-478.
3 Gonzalez-Ros, J.M., Llanillo, M., Paraschos, A. and MartinezCarrion, M. (1982) Biochemistry 21, 3467-3473.
4 Rotstein, N.P., Arias, H.R., Barrantes, F.J. and Aveldano, M.I.
(1987) J. Neurochem. 49, 1333-1340.
5 Criado, M., Eibl, H. and Barrantes, F.J. (1982) Biochemistry 21,
3622-3629.
6 Criado, M., Eibl, H. and Barrantes, F.J. (1984) J. Biol. Chem. 259,
9188-9198.
7 Dalziel, A.W., Rollins, E.A. and McNamee, M.G. (1980) FEBS
Lett. 122, 193-196.
8 Fong, T.-M. and McNamee, M.G. (1986) Biochemistry 25, 830840.
9 Zabrecky, J.R. and Raftery, M.A. (1985) J. Receptor Res. 5,
397-417.
10 Schindler, H. (1982) in Transport in biomembranes: Model systems and reconstitution (Antolirti, R., Gliozzi, A. and Gorio, A.,
eds.), pp. 75-85, Raven Press, New York.
11 Marsh, D. and Barrantes, F.J. (1978) Proc. Natl. Acad. Sci. USA
75, 4329-4333.
12 Marsh, D., Watts, A. and Barrantes, F.J. (1981) Biochim. Biophys.
Acta 645, 97-101.
13 Ellena, J.F., Blazing, M.A. and McNamee, M.G (1983) Biochemistry 22, 5523-5535.
14 Middlemas, D.S. and Raftery, M.A. (1987) Biochemistry 26, 191223.
15 Jones, O.T. and McNamee, M.G. (1988) Biochemistry 27, 23642374.
16 Adams, P.R. (1981) J. Membr. Biol. 58, 161-174.
17 Neher, E. and Steinbach, J.H. (1978) J. Physiol. 277, 153-176.
18 Koblin, D.K. and Lester, H.A. (1979) Mol. Pharmacol. 15, 559580.
19 Heidmann, T., Oswald, R.E. and Changeux, J.-P, (1983) Biochemistry 22, 31123127.
20 Lindstrom, J, Anholt, R., Einarson, B., Engel, A., Osame, M. and
Montal, M. (1980) J. Biol. Chem. 255, 8340-8350.
21 Barrantes, F.J. (1982) in Neuroreceptors (Hucho, F., ed.), pp.
315-328, Walter de Gruyter & Co., Berlin, New York.
22 Sachs, A.B., Lenchitz, B., Noble, R.L. and Hess, G.P. (1982) Anal.
Biochem. 124, 185-190.
23 Schmidt, J and Raftery, M.A. (1973) Anal. Biochem. 52, 349-354.
24 Lowry, O.H., Rosebrough, N.J, Farr, A.L. and Randall, R.J.
(1951) J. Biol. Chem. 193, 265-275.
25 Bonner, R., Barrantes, F.J. and Jovin, T.M. (1976) Nature 263,
429-431.
26 Barrantes, F.J. (1978) J Mol. Biol. 124, 1-26.
27 Kaneda, N., Tanaka, F., Kohno, M., Hayashi, K. and Yagi, K.
(1982) Arch. Biochem. Biophys. 218, 376-383.
28 Noda, M., Takahashi, H., Tanabe, T., Toyosato, M., Kikyotani, S.,
Furutani. Y., Hirose, T., Takashima, H., Inayama, S., Miyata, T.
and Numa, S. (1983) Nature 302, 528-532.
29 Finer-Moore, J. and Stroud, R.M. (1984) Proc. Natl. Acad. Sci.
USA 81, 155-159.
30 Lakowicz, J.R. (1983) in Principles of fluorescence spectroscopy,
Plenum Press, New York.
31 Gonzalez-Ros, J.M., Farach, M.C. and Martinez-Carrion, M.
(1983) Biochemistry 22, 3807-3811.
32 Lee, A.G. (1982) in Techniques in the Life Sciences, Lipid and
Membrane Biochemistry, B4/II (Hesketh, T.R., Kornberg, H.L.,
Metcalfe, J.C., Northcote, C.H., Pogson, C.I. and Tipton, K.F.,
eds.), pp. B422/1-B422/49, Elsevier, Amsterdam.
33 Lechl¢iter, J., Wells, M. and Gruener, R. (1986) Biochim. Biophys.
Acta 856, 640-645.
34 Hille, B. (1977) J. Gen. Physiol. 69, 475-496.
35 Earnest, J.P., Wang, H.H. and McNamee, M.G. (1984) Biochem.
Biophys. Res. Commun. 123, 862-868.
36 Earnest, J.P., Limbacher, H.P., McNamee, M.G. and Wang, H.H.
(1986) Biochemistry 25, 5809-5818.
37 Blanton, M., McCardy, E., Gallaher, T. and Wang, H.H. (1988)
Mol. Pharmacol. 33, 634-642.
38 Horvath, L.I., Arias, H.R., Hideg, K., Hankovszky, H.O., Barrantes, F.J. and Marsh, D. (1990) Biochemistry, in press.
39 Blickenstaff, G.D. and Wang, H.H. (1985) Biophys. J. 47, 261a.
40 Ogden, D.C., Sigelbaum, S.A. and Colquhoun, D. (1981) Nature
289, 596-598.
41 Aracava, Y., Ikeda, S.R., Daly, J.W., Brookes, N. and AIburquerque, E.X. (1984) Mol. Pharmacol. 26, 304-313.
42 Ikeda, S.R., Aronstam, R.S., Daly, J.W., Aracava, Y. and AIburquerque, E.X. (1984) Mol. Pharmacol. 26, 293-303.
43 Schreier-Muccillo, S., Marsh, D. and Smith, I.C.P. (1976) Arch.
Biochem. Biophys. 172, 1-11.
44 Marsh, D. (1982) in Techniques in the Life Sciences, Lipid and
Membrane Biochemistry, B4/II (Hesketh, T.R., Kornberg, H.L.,
Metcalfe, J.C., Northcote, C.H., Pogson, C.I. and Tipton, K.F.,
eds.), pp. B426/1-B426/44, Elsevier, Amsterdam.
45 Lehrer, S.S. (1971) Biochemistry 10, 3254-3263.
46 Fernandez, M.S. and Fromherz, P. (1977) J. Phys. Chem. 81,
1755-1761.